Website intended for a NZ health professional readership
The weather is getting cooler, so pharmacist prescriber Linda Bryant says it’s time to start planning for the onslaught of winter ailments, particularly chronic obstructive pulmonary disease
1. Hancox RJ, Jones S, Baggott C, et al. New Zealand COPD guidelines: Quick reference guide. N Z Med J 2021;134(1530):76–110.
2. Yang IA, George J, McDonald CF, et al. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2022. Version 2.68, October 2022.
3. Cole JM, Sheehan AH, Jordan JK. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease. Ann Pharmacother 2012;46(12):1717–21.
4. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease: 2023 Report.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
